Page 5 - Nasdaq Crsp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq crsp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Crsp Today - Breaking & Trending Today

CRISPR Therapeutics (NASDAQ:CRSP) Given New $90.00 Price Target at Needham & Company LLC

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price objective hoisted by analysts at Needham & Company LLC from $88.00 to $90.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective indicates a potential upside of 8.41% […] ....

Nova Scotia , Samarth Kulkarni , Investment Management , Needham Company , Capital International Investors , Blackrock Inc , T Rowe Price Investment Management Inc , Securities Exchange Commission , Therapeutics Company Profile , Wolfe Research , Pricet Rowe Associates Inc , Royal Bank , Get Free Report , Exchange Commission , International Investors , Rowe Price Investment Management , Crispr Therapeutics , Nasdaq Crsp , Boost Price Target , Needham Amp Company Llc ,

CRISPR Therapeutics AG (NASDAQ:CRSP) Sees Large Decrease in Short Interest

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 15,740,000 shares, a decrease of 7.6% from the January 15th total of 17,040,000 shares. Based on an average daily volume of 2,800,000 shares, […] ....

Samarth Kulkarni , Royal Bank , Headlands Technologies , Wolfe Research , Securities Exchange Commission , Therapeutics Company Profile , Tradewinds Capital Management , Morgan Stanley , Blue Trust Inc , Geneos Wealth Management Inc , Get Free Report , Exchange Commission , Wealth Management , Capital Management , Trading Down , Crispr Therapeutics , Nasdaq Crsp ,

CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 8.3%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was up 8.3% during trading on Thursday . The company traded as high as $85.95 and last traded at $85.62. Approximately 985,528 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 2,003,556 shares. The stock had previously closed at $79.04. […] ....

Nova Scotia , Samarth Kulkarni , Vanguard Group Inc , Pricet Rowe Associates Inc , Investment Management , Blackrock Inc , Royal Bank , Wolfe Research , Get Free Report , Street Corp , Vanguard Group , Crispr Therapeutics , Nasdaq Crsp ,

CRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 20,000 Shares of Stock

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) CEO Samarth Kulkarni sold 20,000 shares of the stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $80.36, for a total transaction of $1,607,200.00. Following the transaction, the chief executive officer now directly owns 187,377 shares in the company, […] ....

Samarth Kulkarni , Fairfield Bush , Securities Exchange Commission , Therapeutics Company Profile , Blackrock Inc , Morgan Stanley , Us Bancorp , Needham Company , Cibc World Market Inc , York Mellon Corp , Get Free Report , Exchange Commission , Stock Down , New York Mellon Corp , Cibc World Market , World Market , Crispr Therapeutics , Nasdaq Crsp , Insider Trading , Nsider Trades ,

Value Star Asset Management Hong Kong Ltd Acquires Shares of 17,650 CRISPR Therapeutics AG (NASDAQ:CRSP)

Value Star Asset Management Hong Kong Ltd acquired a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 17,650 shares of the company’s stock, valued at approximately $801,000. CRISPR Therapeutics comprises […] ....

Hong Kong , Samarth Kulkarni , Exchange Commission , Us Bancorp , Blackrock Inc , York Mellon Corp , Fairfield Bush , Cibc World Market Inc , Value Star Asset Management Hong Kong Ltd , Needham Company , Free Report , New York Mellon Corp , Cibc World Market , World Market , Trading Down , Get Free Report , Visit Holdingschannel , Crispr Therapeutics , Nasdaq Crsp , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,